Secondary Stroke Prevention with Low-Dose Aspirin, Sustained Release Dipyridamole Alone and in Combination
Author:
- 15 September 1998
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 92 (1) , S1-S6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeJournal of the Neurological Sciences, 1996
- Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- European Stroke Prevention Study. ESPS Group.Stroke, 1990
- Dipyridamole alone or combined with low‐dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo [see comments]British Journal of Clinical Pharmacology, 1990